NCGM, Inc. is part of Neuberg Diagnostics, a global clinical laboratory chain that combines the best technologies and assays emphasizing affordability & access.

We are proud to play an active role in the fight against COVID-19. Our services are designed to:

  • Support healthcare providers by keeping their employees safe and testing patients
  • Assist educational institutions with reopening and protecting the health of individuals
  • Help businesses reopen their workplaces and keep employees and customers safe
  • Enable government to keep their local and regional communities safe, including residents at long term care facilities, and others
  • Help individuals with testing on affordable basis


Full Service


  • TaqPathTM COVID-19 Combo Kit contains the assays and controls for a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid (RNA) from SARS-CoV-2 in upper respiratory specimens in acute phase of infection
  • Sample types bronchoalveolar lavage (BAL), mid-turbinate swabs, nasal swabs, nasopharyngeal swabs, nasopharyngeal aspirate (nasal aspirate), and oropharyngeal swabs (see Fig 1).
  • Assays target three coronavirus genes: orf-1ab, S, and N having higher specificity with lower risk for mutation.
  • Each run covers 94 specimens in 3 hours allowing turnaround (from sample receipt to report) within 24-48 hours.
  • Positive results are indicative of the presence of SARS-CoV-2 RNA. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.
  • Intended use under Food and Drug Administration’s Emergency Use Authorization limited to Clinical Laboratory certified under CLIA 88.

Work Flow

Enquire Now